SCHEMBL7984754

SCHEMBL7984754

CCc1nc(O)c2c(ncn2Cc2cccc(Cl)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
GLA P06280 1/20 0.47
HTT P42858 1/20 0.47
UBE2N P61088 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
YTHDC1 Q96MU7 3/20 0.44
ACP1 P24666 1/20 0.43
EGLN1 Q9GZT9 1/20 0.41
CNR2 P34972 4/20 0.40
HTR6 P50406 1/20 0.40
FSCN1 Q16658 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 1/20 0.38
GAA P10253 1/20 0.38
BRD4 O60885 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991724 0.92 SMN1; SMN2 (0.47) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7975252 0.88 HPGD (0.45) SMN1; SMN2YTHDC1GAACYP11B1CYP11B2
SCHEMBL7987673 0.88 YTHDC1 (0.47) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974260 0.87 CYP11B1 (0.47) SMN1; SMN2GLAHTTGAAADORA2A
Hydrochloric Acid SCHEMBL7987804 0.87 YTHDC1 (0.46) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988674 0.86 SMN1; SMN2 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7984208 0.86 MAPT (0.39) SMN1; SMN2KDM4EMAPK1GAABRD4
SCHEMBL7984497 0.84 MET (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7984512 0.84 GAA (0.50) YTHDC1GAAADORA2AADORA1
SCHEMBL7988129 0.83 MET (0.44) SMN1; SMN2MAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed